{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:33:16Z","timestamp":1791509596022,"version":"4.3.4"},"reference-count":66,"publisher":"Wiley","license":[{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023812","name":"St Vincent's Curran Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1196900"],"award-info":[{"award-number":["1196900"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["196560"],"award-info":[{"award-number":["196560"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012187","name":"St. Vincent's Clinic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin\u2010assisted psychotherapy for methamphetamine use disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Single arm, open label pilot study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Outpatient public stimulant treatment program at St. Vincent's Hospital, Sydney, Australia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>We recruited 15 participants that were \u226525\u2009years old, seeking treatment for methamphetamine use, using methamphetamine \u22654\u2009days\/month at screening, and without serious mental illness or contraindicated medical conditions or medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Participants received three preparatory psychotherapy sessions over two weeks before a single psilocybin dosing session (25\u2009mg oral), followed by two integration psychotherapy sessions over one week. Psychotherapy included elements of motivational enhancement and acceptance and commitment therapy. Participants were followed for 90\u2009days post psilocybin\u2010assisted psychotherapy session.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>Primary endpoints were safety (as measured by adverse events over the trial and vital signs during psilocybin dosing) and feasibility (as measured by enrolment and dropout rates), and secondary endpoints included measuring self\u2010reported methamphetamine and other illicit drug use, drug craving, depression, anxiety, stress and quality of life measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Of 56 participants pre\u2010screened, 15 were eligible and enrolled, 14 completed the intervention and 13 completed 90\u2010day post\u2010dose follow\u2010up.\u201d. No serious adverse events (AEs) occurred, and the seven treatment related AEs were self\u2010limiting and mild to moderate in severity. AEs included hypertension during the dosing session and headache (n\u2009=\u20094), nausea (n\u2009=\u20091) and noise sensitivity (n\u2009=\u20091) within the week following the dose. Methamphetamine use (over the prior 28\u2009days) was observed to be higher at screening (median 12\u2009days, IQR 7\u201316, n\u2009=\u200915) relative to day 28 (median 0\u2009days, IQR 0\u20132, n\u2009=\u200913) and 90 (median 2\u2009days, IQR 1\u20134, n\u2009=\u200914) post psilocybin. [Correction added on 20 November 2025, after first online publication: In the preceding sentence, \u2018lower\u2019 has been changed to 'higher' in this version.] Methamphetamine craving was also observed to be lower while quality of life, depression, anxiety, and stress were observed to be higher at days 28 and 90 follow\u2010up relative to baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Psilocybin assisted psychotherapy for methamphetamine use disorder was feasible to implement in an outpatient setting and did not appear to generate safety concerns. A larger randomised controlled trial is required to confirm efficacy and safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/add.70187","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:09:06Z","timestamp":1758366546000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Psilocybin\u2010assisted psychotherapy for methamphetamine use disorder: A pilot open\u2010label safety and feasibility study"],"prefix":"10.1111","author":[{"given":"Elizabeth","family":"Knock","sequence":"first","affiliation":[{"name":"St\u2009Vincent\u2019s Hospital Alcohol and Drug Service  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6534-3325","authenticated-orcid":false,"given":"Krista J.","family":"Siefried","sequence":"additional","affiliation":[{"name":"St\u2009Vincent\u2019s Hospital Alcohol and Drug Service  Sydney New South Wales Australia"},{"name":"The National Centre for Clinical Research on Emerging Drugs of Concern (NCCRED), The University of New South Wales  Sydney New South Wales Australia"},{"name":"National Drug and Alcohol Research Centre (NDARC) The University of New South Wales  Randwick New South Wales Australia"},{"name":"New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN), Ministry of Health  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-0099","authenticated-orcid":false,"given":"Gill","family":"Bedi","sequence":"additional","affiliation":[{"name":"Centre for Youth Mental Health Orygen  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Albert","sequence":"additional","affiliation":[{"name":"School of Psychiatry, Faculty of Medicine University of New South Wales  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-6937","authenticated-orcid":false,"given":"Richard O.","family":"Day","sequence":"additional","affiliation":[{"name":"St\u2009Vincent\u2019s Clinical Campus University of New South Wales  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7495-8305","authenticated-orcid":false,"given":"Nadine","family":"Ezard","sequence":"additional","affiliation":[{"name":"St\u2009Vincent\u2019s Hospital Alcohol and Drug Service  Sydney New South Wales Australia"},{"name":"The National Centre for Clinical Research on Emerging Drugs of Concern (NCCRED), The University of New South Wales  Sydney New South Wales Australia"},{"name":"National Drug and Alcohol Research Centre (NDARC) The University of New South Wales  Randwick New South Wales Australia"},{"name":"New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN), Ministry of Health  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Psychosocial Cancer Care St\u2009Vincent\u2019s Hospital Melbourne  Fitzroy Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-2263","authenticated-orcid":false,"given":"Paul","family":"Liknaitzky","sequence":"additional","affiliation":[{"name":"Department of Psychiatry School of Clinical Sciences Monash University  Clayton Victoria Australia"},{"name":"School of Psychological Sciences Monash University  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3065-7495","authenticated-orcid":false,"given":"Jonathan","family":"Brett","sequence":"additional","affiliation":[{"name":"St\u2009Vincent\u2019s Clinical Campus University of New South Wales  Sydney New South Wales Australia"},{"name":"School of Population Health University of New South Wales  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"World Drug Report 20192019."},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119841569"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115581980"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32230-5"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14755"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint14010015"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00711-x"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011866.pub3"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201700242"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03933.x"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/1355621021000005937"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2047929"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2016.1170135"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2096"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.05.012"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1123424"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-1"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/nur.20247"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-068884"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.283"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1490907"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093587"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565144"},{"key":"e_1_2_11_27_1","doi-asserted-by":"crossref","unstructured":"GussJ Krause R. Sloshower J.The Yale Manual for Psilocybin\u2010Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame).2020.","DOI":"10.31234\/osf.io\/u6v9y"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897071003641578"},{"key":"e_1_2_11_29_1","unstructured":"Guide to good manufacturing practice for medicinal products (PE009\u201316)Therapeutic Goods2024"},{"key":"e_1_2_11_30_1","unstructured":"The Royal Australian and New Zealand College of Psychiatrists.2023Therapeutic Use of Psychedelic Substances"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1614.1999.00517.x"},{"key":"e_1_2_11_32_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).Medical Dictionary for Regulatory Activities (MedDRA) Version 24.1. Geneva: ICH; September2021."},{"key":"e_1_2_11_33_1","unstructured":"Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events(2017)."},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2017.10.028"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116678781"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0457-5"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0030992"},{"key":"e_1_2_11_38_1","unstructured":"US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER).Stimulant use disorders: Developing drugs for treatment guidance for industry: Draft guidance2023"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00132576-200211000-00005"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-5-63"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.10.2.176"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774512465064"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855974"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0034473"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-012-0322-4"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1982.51.2.663"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06187-5"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.16409"},{"key":"e_1_2_11_49_1","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.72352"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881115609019"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1134454"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078084"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114548296"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221116926"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811231200019"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881121991822"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291723003653"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06221-6"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.661233"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00169"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108094300"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.04.105"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcbs.2019.12.004"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58318-x"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00711-x"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.70187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:40:20Z","timestamp":1763700020000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.70187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":66,"alternative-id":["10.1111\/add.70187"],"URL":"https:\/\/doi.org\/10.1111\/add.70187","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,20]]},"assertion":[{"value":"2025-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"add.70187"}}